Full Length Research Paper
References
Alvarez L, Rios MY, Esquivel C, Chavez MI, Delgado G, Aguilar MI (1999). Cytotoxic isoflavans from Eysenhardtia polystachya. J. Nat. Prod. 61:767-770. crossref |
||||
Alvarez L, Delgado G (1999a). C- and O-Glycosyl-cx-hydroxydihydrochalcones from Eysenhardtia polystachya. Phytochemistry 50:681-687. crossref |
||||
Aggarwal BB, Gutterman JU (1992). Tumor necrosis factor. Human Cvtokines. Blackwell Scientific Publications: Boston, MA, USA. | ||||
Ammon HPT, Annazodo MI, Safayhi H, Dhawan BN, Scrimal R (1992). Curcumin: a potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Med. 58:226-229. crossref |
||||
Arrigoni-Martelli E, Bramm E (1975). Investigations in the influence of cyclophosphamide gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis. Agents Actions 5:264-267. crossref |
||||
Bradley PP, Priebat DA, Chiristensen RD, Rothstein G (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 78:206-209. crossref |
||||
Burns DT, Dalgarno BG, Ggargan P, Grimshaw J (1984). An isoflavone and a coumestan from Eysenhardtia polystachya-robert boyle's fluorescent acid-base indicator. Phytochemistry 3:167-169. crossref |
||||
Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Yá-ez M (2009). Chalcones: A valid scaffold for monoamine oxidases inhibitors. J. Med. Chem. 52:2818–2824. crossref |
||||
Crofford LJ, Tan B, McCarthy CJ, Hia T (1997). Involvement of nuclear factor Kappa B in the regulation of ciclooxygenase-2 expression by interlukin-1 in rheumatoid synoviocytes. Arthitis Rheum. 40:226-236. crossref |
||||
Dunne MW (1990). Pathophysiology: Concepts of Altered Health States with Contributors,' ed. by Porth C. M., Lippincott, Philadelphia. pp. 165-176. | ||||
Gepdiremen A, Mshvildadze V, Suleyman H, Elias R (2004). Acute and chronic anti-inflammatory effects of Hedera cochica in rats, J. Ethnopharmacol. 94:191-195. crossref |
||||
Gupta M, Mazumdar UK, Sivakumar T, Laxmi MV, Somalingappa SK, Sambathkumar R, Manikandan L (2003). Evaluation of anti-inflammatory activity of chloroform Extract of Bryonia laciniosa in experimental animal models. Biol. Pharm. Bull. 26:1342-1344. crossref |
||||
Jing-Rong W, Hua Z, Zhi-Hong JG, Yuen FWG, Liang L (2008). In vivo anti-inflammnatory and analgesic activities of a purified saponin fraction derived from the root of Ilex pubescens. Biol. Pharm. Bull. 31:643-650. crossref |
||||
Halliwill B (1996). Antioxidants in human health and diseases. Ann. Rev. Nutr. 16:33-50. crossref |
||||
Luster ML, Dean JH, Boorman GA (1982). A cell mediated S immunity and its application in toxicology. En vivo Health Perspect. 43:31-36. crossref |
||||
Lyckander IM, Malterud KE (1992). Lipophilic flavonoids from Orthosiphon spicatus as inhibitors of 15-lipoxygenase. Acta Pharm. Nordica. 4:159-166. | ||||
Narvaez-Mastache JM, Novillo F, Delgado G (2008). Antioxidant aryl- prenylcoumarin, flavan-3-ols and flavonoids from Eysenhardtia subcoriacea. Phytochemistry. 69: 451-456. crossref |
||||
Owen PL, Timothy J (1999). Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout. J. Ethnopharmacol. 64:149-160. crossref |
||||
Perez RMG, Vargas R, Perez GS, Zavala S (1998). Antiurolithiatic activity of Eysenhardtia polystachya aqueous extract on rats- Phytoter. Res. 12:144-145. | ||||
Gutierrez RM, Baez EG (2014). Evaluation of hypoglycemic, antioxidant and antiglycating activities of the Eysenhardtia polystachya. Pharmcog. Mag. (Supplement 2)10:S404-S418. crossref |
||||
Recio MC, Giner RM, Manez S, Ros JL (1995). Structural requirements for the anti-Inflammatory activity of natural triterpenoids. Planta Med. 61:182-185. crossref |
||||
Rotelli AE, Guardia T, Juárez AO, De La Rocha NE, Pelzer LE (2003) Comparative study of flavonoids in experimental models of inflammation. Pharmacol. Res. 48:601-606. crossref |
||||
Schrader JW, Thompson AW (1994). The cytokine Hanbook, 2nd edn. Academic Press: London UK. | ||||
Van Arman CG (1974). Anti-inflammatory drugs. Clin. Pharm. Ther. 16:900-904 Pubmed |
||||
Washiyama M. Sasaki, Y, Hosokawa T, Nagumo S (2009). Anti-inflammatory constituents of Sappan lignum. Biol. Pharm. Bull. 32:941-944. crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0